Close

Huffington Post Blog

Entries from Dr. Brggin’s Huffington Post blog are mirrored here.

Pregnant Mothers Should Not Take SSRI Antidepressants

On June 28, 2007 more than 250 headlines around the world promised that SSRI antidepressants (such as Prozac, Paxil, Zoloft, and Celexa) are safe for pregnant mothers and their developing babies. “Mom’s Antidepressant Use Poses Little Danger to Baby,” heralded the Atlanta Journal Constitution. “Antidepressants pose low birth defect risk,” claimed Boston Globe. The New York Times ran with the Associated Press’s article titled “Antidepressants Not Big Risk for Defects.” The Wall Street Journal’s coverage was titled “Reassurance on Antidepressants in Pregnancy.” The day before the news stories broke, the Centers for Disease Control spun the news in advance with a press release headlined, “New Study Finds Few Risks of Birth Defects from Antidepressant Use During Pregnancy” (CDC Division of Media, 2007).

Read More

The Real “Mental Health Lessons” from Virginia Tech

Focusing on Virginia Tech mass murderer Cho as a disturbed mental patient has led media analysts to ponder how he could have been more readily identified by the mental health system. But Cho is not someone who slipped beneath the psychiatric radar. Instead, he was frequently detected as a large object on the screen. On separate occasions, he was involuntarily hospitalized, sent for psychological evaluation, and referred to the university counseling center. Consistent with getting him more psychiatric “help,” experts have also opined on how he might have benefited from medication. These are all the wrong lessons.

Read More

Baseball Pitcher Struck by Antidepressant Madness

Recent reports in media describe retired star baseball pitcher Jeff Reardon as commiting a senseless robbery typical of victims of antidepressant-induced madness. Apparently taking numerous antidepressants, Jeff Reardon, a wealthy former baseball player, impulsively robbed a jewelry store armed with the threat of a non-existent gun. Instead of walking out with valuable jewelry, he left with $170 in a bag. Reardon was so aghast by his own actions, he turned himself in to a security guard on the way out of the mall, explaining to the surprised guard, “I completely lost my mind.” Later he told the police, “I flipped on my medications.” Reardon had been in treatment following the death of his son by an overdose two years earlier.

Read More

Suppressed Paxil Suicide and Stimulation Data Released

Newly released information demonstrates that the manufacturer of Paxil withheld key data concerning the risks associated with its antidepressant Paxil. The drug company Glaxo SmithKline failed to release its complete data concerning rates of suicidality on Paxil. In the information that was originally provided to the FDA, the number of suicide attempts on the antidepressant Paxil was under-reported and the number of suicide attempts on placebo was inflated. The drug company also hid the stimulating effects of the drug that pose a potential risk for causing violence.

Read More

The Big Suicide Loophole in Antidepressant Drug Safety Studies

On December 13, 2006 the FDA’s Psychopharmaceutical Drugs Advisory Committee (PDAC) is meeting in Silver Spring, Maryland to discuss antidepressant-induced suicidal behavior in adults. In 2004 the FDA held similar hearings on children and concluded that antidepressants do in fact cause suicide in humans under age eighteen. A warning has been placed in all antidepressant labels or package inserts.

Read More